Unlocking Market Access with AI

The 'Life Sciences DNA' Podcast, sponsored by Agilisium Labs, delves into the essential topic of market access for drugs. In this episode, the host engages in an insightful conversation with industry experts to explore how pharmaceutical companies leverage data analytics and AI to navigate the complex landscapes of payers, pricing, and regulations.

Episode Highlights:

• Understanding Market Access: Start by demystifying market access. For those new to the commercial side of pharma, this section explains what market access means and its vital importance for drug companies.
• Value Proposition: The discussion covers the clinical, patient, and healthcare system value of a medicine, exploring how these factors influence market access decisions.
• Global Perspectives: Significant differences in market access strategies between the US and other countries are examined, highlighting the unique challenges that pharmaceutical companies face in varying regulatory environments.
• AI Trends in Market Access: The episode delves into current trends at the intersection of AI and market access, showcasing how AI is shaping the way companies demonstrate the value of their medicines.
• Pricing Strategies: Finally, an analysis of how AI can assist in setting drug prices across various countries is presented, discussing the innovative use cases that are driving this transformation.